OUR PRODUCTS

MOBILE APPS

GENERAL INFO

IPSC

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Century Therapeutics (IPSC) Earnings Date & Reports

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IPSC is expected to report earnings to fall 142.70% to -37 cents per share on August 11

Century Therapeutics IPSC Stock Earnings Reports

Q2'25

Est.

$-0.38

Q1'25

Beat

by $0.96

Q4'24

Est.

$-0.41

Q3'24

Beat

by $0.08

Q2'24

Beat

by $0.07

The last earnings report on May 16 showed earnings per share of 88 cents, beating the estimate of -7 cents. With 371.17K shares outstanding, the current market capitalization sits at 43.71M.

View a ticker or compare two or three

Compare

IPSC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For IPSC
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IPSC showed earnings on May 16, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

25 N 38th Street

Phone

+1 267 817-5790

Employees

165

Web

https://www.centurytx.com